换一批
换一批Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
作者：
主题词
成年人(Adult);抗体, 单克隆(Antibodies, Monoclonal);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗原, CD34(Antigens, CD34);抗肿瘤药(Antineoplastic Agents);骨髓净化(Bone Marrow Purging);综合疗法(Combined Modality Therapy);流式细胞术(Flow Cytometry);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);造血干细胞动员(Hematopoietic Stem Cell Mobilization);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);淋巴瘤, 膜细胞(Lymphoma, Mantle-Cell);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);中年人(Middle Aged);肿瘤, 残余(Neoplasm, Residual);挽救疗法(Salvage Therapy);移植, 自体(Transplantation, Autologous)
PMID
10561026
发布时间
2015-11-19
- 浏览30
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
